Four therapeutic directions.
One data-driven AI engine.

Podigy is advancing AOC oligonucleotide therapeutics, antibody therapeutics, targeted protein degradation (TPD), and next-generation kidney-targeted AAV for precision treatment of kidney diseases, supported by a wet-lab-data-driven design and validation engine. We currently disclose program codes, indications, modalities and development stages; specific targets and candidate mechanisms remain undisclosed.